Bids Are Invited For Price Registration For The Eventual Supply Of General Clinical Medicines (Sei: 0040609437.000003/2025-37)

(3067530) - Atenolol - Concentration/Dosage 50 Mg, Compressed Pharmaceutical Form, Oral Administration Route, (3166210) - Atropine, Sulfate - Concentration/Dosage 10 Mg/Ml, Pharmaceutical Form Ophthalmic Solution, Ophthalmic Administration Form, (3166457) - Carbacol - Carbacol - Carbacol - Carbacol Concentration/Dosage 0, 1 Mg/Ml, Pharmaceutical Form Solution, Form Of Introduction, Via Intraocular Administration, (1126679) -Anesthesic Colirium, With Tetracainh Hydrochloride, Phenylephrine Hydrochloride, Boric Acid, Packed In Freshwater Bottles 10 Ml, (3350908) -(3350908) Dexamethasone + Neomycin Sulfate + Polymyxin Sulfate B - Concentration/Dosage 1 Mg/G + 5 Mg/G + 6,000 Iu/G Respectively, Pharmaceutical Form Ophthalmic Ointment, Tube Presentation, 30/04/2025, (3175871) - Dexamethasone + Polymix Sulfate B - Concentration/Dosage 1 Mg/Ml + 5 Mg/Ml + 6,000 Iu/Ml Respectively, Pharmaceutical Form Ophthalmic Suspension, (3202968) - Ethyl Estres Of Iodada Papo -Poppy Gray Acids - Iodine Composition 480 Mg/Ml, Pharmaceutical Form Injectable Solution, Form Of Ampolha, Intralymphatic Administration. (3282066) - Phenylephrine, Hydrochloride - Concentration/Dosage 100 Mg/Ml, (3086933) - Phenoterol, Bromidrate - Concentration/Dosage 5 Mg/Ml, Pharmaceutical Form For Inhalation, (3181472) - Potassium Phosphate 2 Meq/Ml, Intravenous Administration Route, (4860802) - Sodium Hyposulfite - Concentration/Dosage 250 Mg/Ml, Endovenous Administration Route, (3575756) - Lidocaine, Hydrochloride - Concentration/Dosage 10 Mg/Ml, Percutaneous Or Parenteral Administration Route, (3347125) - Moxifloxacin, Hydrochloride - Concentration/Dosage 5 Mg/Ml, (3204820) - Proximetacaine, (4385802) - Tobramicin + Dexamethasone - Concentration/Dosage 3 Mg/G + 1 Mg/G Respectively, (3192385) - Tobramycin + Dexamethasone - Concentration/Dosage 3 Mg/Ml + 1 Mg/Ml Respectively